European Commission logo
Program

Enhancing Cell Therapies With Genomic Engineering

Funds research teams that use gene and epigenome editing to engineer safer, more effective off-the-shelf cell therapies for one chosen disease area.

The European Commission funds Research and Innovation Action grants for consortia that build synthetic genetic circuits into the chosen cells, test them in relevant pre-clinical models, and confirm safety and efficacy in vivo. Five awards are expected, and the Commission balances funding across different therapeutic areas rather than ranking alone.

BiotechMedtech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.